Consensus has reported robust financial results for the second quarter of 2024, surpassing analyst expectations with significant increases in revenue, adjusted EBITDA, adjusted earnings, and free cash flow. The company has successfully streamlined operations, particularly in the SoHo channel, while expanding its footprint in the healthcare sector. With a strategic focus on cost reduction and debt management, Consensus has managed to maintain a stable average revenue per account (ARPA) and has even increased its adjusted EPS guidance for the full year.
Key Takeaways
- Consensus beat Q2 2024 expectations with higher revenue, adjusted EBITDA, earnings, and free cash flow.
- The company reduced total debt to $649 million, with a $29.7 million debt repurchase in the quarter.
- ARPA remained stable at $310, thanks to new customer acquisitions and e-commerce upgrades in the corporate channel.
- The public sector, especially the VA rollout, is experiencing steady growth, suggesting future revenue potential.
- Consensus plans to increase marketing spend by $2 million in H2 2024, despite a smarter ad strategy that boosted profitability.
- The company has reaffirmed its full-year 2024 revenue and adjusted EBITDA guidance and raised its adjusted EPS forecast.
Company Outlook
- Full-year 2024 revenue and adjusted EBITDA guidance reaffirmed by the company.
- Adjusted EPS guidance for the full year has been increased.
- Anticipated revenue from the accelerated service rollout to various facilities is around $2 million for the year, with significant growth expected in 2025.
Bearish Highlights
- The SoHo channel saw a revenue decrease of 15.8% compared to the previous year.
- Despite the decrease, the SoHo business is expected to decline at a slower rate in Q3 and Q4 compared to Q2.
- The company's clarity prior auth solution is growing interest but has not yet made a significant contribution to revenue.
Bullish Highlights
- Q2 revenue for the corporate business increased by 2.7% over the previous year.
- The SoHo channel performed better than expected due to reduced marketing spend and efficient paid ads.
- The public sector business is showing promising growth, particularly with the VA rollout.
Misses
- No specific misses were highlighted in the summary provided.
Q&A Highlights
- The company discussed their service rollout acceleration, cost optimization for struggling hospitals, and marketing spend expectations.
- Consensus expects a smaller decline in the SoHo business in the latter half of 2024 and a stabilized run rate in 2025.
- Capital deployment plans include addressing debt refinancing options in 2025 and maintaining a similar CapEx level for the year.
As Consensus continues to navigate the challenges and opportunities within its market, the company remains focused on improving its cost structure and optimizing its marketing strategies. With a clear plan for capital deployment and a commitment to reducing debt, Consensus appears poised for sustained growth, particularly in the healthcare sector. Investors and stakeholders can look forward to the Q3 results announcement in November for further insights into the company's performance and strategic direction.
InvestingPro Insights
Consensus's recent financial achievements have been noteworthy, and a closer look at the company through the lens of InvestingPro data and tips may provide investors with a deeper understanding of its current market position and potential.
InvestingPro Data shows that Consensus has a market cap of $374.41 million as of Q1 2024. The company's gross profit margin is impressive, standing at 81.11% for the last twelve months as of Q1 2024, reflecting its ability to maintain high profitability in its operations. Moreover, Consensus boasts a strong operating income margin of 42.0%, signaling efficient management and robust operational performance.
Two InvestingPro Tips that stand out for Consensus include the aggressive share buyback initiative by management and the positive revisions by analysts on the company's earnings for the upcoming period. Management's decision to buy back shares could be indicative of their confidence in the company's value, while the earnings revisions suggest that financial experts anticipate continued growth and profitability for Consensus.
As of Q1 2024, Consensus is trading at a low P/E ratio of 4.25 relative to near-term earnings growth, which could attract investors looking for undervalued stocks with growth potential. Additionally, the company has demonstrated a strong return over the last month with a 15.13% price total return, highlighting recent positive investor sentiment.
For investors interested in a more detailed analysis, there are additional InvestingPro Tips available, providing insights into other factors such as stock price volatility, profitability projections, and dividend policies. Access to these tips can be found on the InvestingPro platform at https://www.investing.com/pro/CCSI.
Full transcript - Consensus Cloud Solutions Inc (CCSI) Q2 2024:
Operator: Good day ladies and gentlemen, and welcome to Consensus Q2 2024 Earnings Call. My name is Paul and I will be the operator assisting you today. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation [Operator Instructions] On this call from Consensus will be Scott Turicchi, CEO; Jim Malone, CFO; Johnny Hecker, CRO and Executive Vice President of Operations; and Adam Brown, Senior Vice President of Finance. I will now turn the call over to Adam Brown, Senior Vice President of Finance at Consensus. Thank you. You may begin.
Adam Brown: Good afternoon and welcome to the Consensus investor call to discuss our Q2 2024 financial results, other key information, our Q3 2024 quarterly guidance, and full-year 2024 guidance Joining me today are Scott Turicchi, CEO; Johnny Hecker, CRO and EVP of Operations; and Jim Malone, CFO. The earnings call will begin with Scott providing opening remarks. Johnny will give an update on operational progress since our Q1 2024 investor call, and then Jim will discuss Q2 2024 financial results, our Q3 2024 quarterly and full-year 2024 guidance. After we finish our prepared remarks, we will conduct a Q&A session. At that time, the operator will instruct you on the procedures for asking a question. Before we begin our prepared remarks allow me to direct you to our forward-looking statements and risk factors on Slide 2. As you know, this call and the webcast will include forward-looking statements. Such statements may involve risks and uncertainties that would cause actual results to differ materially from the anticipated results. Some of those risks and uncertainties include, but are not limited to the risk factors that we have disclosed in our 10-K SEC filing. Now, let me turn the call over to Scott.
Scott Turicchi: Thank you, Adam. We had a strong Q2 outperforming on both channels of revenue, adjusted EBITDA, adjusted earnings, adjusted EPS, and free cash flow. As we laid out in our Q4 earnings call, our goals for this year include the following. First, eliminating certain costs of the SoHo channel, especially in the area of marketing, to provide for stabilization of the base of revenue over time. Second, continuing to pursue the acquisition of customers primarily in the healthcare space for our corporate channel. Third, reviewing and improving our overall cost structure with the goal of driving adjusted EBITDA margins to the higher end of our 50% to 55% range. And fourth, continuing to repurchase our debt to further reduce our total debt to adjusted EBITDA ratio in anticipation of the first tranche maturing in October 2026. Let me provide a few additional highlights before turning the call over to Johnny. Our corporate channel continued to add new customers, primarily through upgrades from our SoHo base as well as our relatively new e-commerce offering eFax Protect. Notwithstanding the lower ARPA of these customers than our current average, we were still able to maintain a $310 ARPA and a tight range over the past several quarters of between $305 and $320. We continue to see additional sites from the VA rolling out, driving new levels of and revenue. Our SoHo revenues beat our expectations for the quarter. I would remind you that in Q2 2023, we finished the price increase to our base and actually saw a slight growth in revenues versus Q2 2022. As we stated, at the time, we viewed this growth as anomalous. We continue to track ahead of our 2023 budget and have found additional marketing opportunities while maintaining a strong LTV to CAC. We were able to substantially reduce our marketing spend and still generate 61,000 paid ads more than Q4 2023, and similar to Q3 2023, which had higher levels of spend. Our cost structure benefited from a full quarter of the cost optimization that we discussed on our Q4 call. As a reminder, most of those cost reductions came primarily from the SoHo marketing mentioned earlier. The result was a 4.7 percentage point pickup on our adjusted EBITDA margin to 56.1% for the quarter, which is above the upper end of our long-term range. The combination of improved adjusted EBITDA, strong cash collections, and retirement of debt allowed us to improve our free cash flow by more than 11 million from Q2 2023. We were able to repurchase an additional 29.7 million of debt during the quarter. This brings our total repurchases since launching the program in November of 2023 to 156 million and reducing our outstanding total debt to 649 million or 3.4x our trailing 12-month adjusted EBITDA and 3.1 times on a net debt basis. I will now turn the call over to Johnny, who will provide you more operating details.
Johnny Hecker: Thank you, Scott, and hello everyone. Today I will share business and go-to-market updates covering both our corporate and SoHo businesses, along with more details on the public sector, specifically the VA rollout and product enhancements. Let's start by sharing our sales and operations update and then the solid performance in the corporate business. We are pleased to report revenue of $51.7 million versus $50.4 million last year for Q2 marking an approximate 3% increase over the same period last year. This outcome serves as a testament to use cases for cloud fax in corporate settings, especially in healthcare. I am most pleased with the increase in the variable portion of our revenues, indicating mostly upmarket growth. It marks another record-setting quarter for our corporate business, emphasizing the unwavering strength and effectiveness of our offerings. The e-commerce and SoHo upsell strategy continues to be a valuable source of customer acquisition with approximately 2,700 customers added in Q2 demonstrating the effectiveness of our strategy. During the last call, we projected a decline in our SoHo to corporate upsell during Q2 due to planned operational changes. However, the growth of our eFax Protect service helped us offset the slowdown to a large extent. We will continue to invest in and expand this e-commerce offering, which aligns with the go-to-market realignment strategy we shared last year. The next phase of this offering will include in-product upsell options for our customers, eliminating the need for in-person interaction with customers for that process. The metrics we share reveal that the growth in corporate accounts driven by those new customers at the lower end of our customer continuum also leads to a higher corporate cancellation rate. It has increased by 103 basis points year-over-year and 37 basis points quarter-over-quarter, reaching 2.29% in the second quarter of 2024. Normalized for eFax Protect, the cancer rate in corporate, remain significantly below the 2% mark. I would remind you that our cancellation rate is based on accounts and not on revenue. We foresaw this trend with the launch of the e-commerce channel and are pleased to report that corporate ARPA has remained steady for several quarters within the $305 to $320 range at just above $310 this quarter. During Q2, advanced products accounted for 14% of new sales aligning with the performance of the second half of the last year while being lower than the Q1 contribution. This temporary slowdown is mainly attributed to our Unite offering after a strong sales performance in Q1. It's important to note that this percentage fluctuates and is also influenced by the new sales of our core fax services. Overall, we're on track with the execution of our go-to-market plan in 2024. We're increasingly closing customers in the lower ARPA spectrum through fully automated e-commerce processes, allowing for our sales team to focus on larger deals driving up overall sales productivity. I'd also like to highlight our public sector business. The implementation of EC Fax at the VA is proceeding as planned, and our enthusiasm for its potential remains unwavering. We are observing steady growth in line with our projections, and we confidently confirm that we forecast more than $2 million in revenue from the EC Fax program in 2024 and expect continued growth in the coming months and years as we move forward. EC Fax stands out as the sole cloud fax solution on the FedRAMP marketplace with the additional exceptional distinction of complying with the high impact level controls. This attests to the utmost level of security, integrity, and availability vital for government agencies operating in sensitive sectors like law enforcement, healthcare, finance, and defense. As we advance our relationships with these agencies, it becomes increasingly apparent that meeting the FedRAMP high impact standard is a prerequisite for even being considered as a potential solution by the government. We are pleased to share the discussions with other agencies are proceeding. We're witnessing heightened demand for our solutions in a second relevant area of the public sector, state and local government, and education. This prompts us to explore strengthening our emphasis on the public sector as a critical pillar in our corporate business beyond healthcare and commercial as we approach our 2025 planning process. Regarding our cloud fax business, we remain committed to investing in the ongoing development and enhancement of our cloud fax platform. Adopting a fully cloudified approach has demonstrated to be the optimal strategy, particularly in terms of scalability, resilience, and innovation. We consistently strive to enhance the platform, keeping our customers' best interest at the forefront, while ensuring our continued economic success. We continue to receive robust interest in our AI offering Clarity, which leverages our proprietary LLM and related technologies to unlock valuable insights from unstructured data. Customers and potential clients are particularly intrigued by the possibility of tailoring Clarity models to their specific use cases, enabling them to extract actionable intelligence and automate workflows in ways never before possible. This heightened interest is reflected in the growing number of proof-of-concept requests, which are currently contributing to our expanding implementation backlog. Turning to our SoHo business, Q2 revenue was $35.8 million versus $42.4 million previous year, consistent with the focused marketing changes we announced last year, the total SoHo account base has decreased from 808,000 to 785,000 during the quarter. Similar to last quarter, we again remain slightly ahead of expectations with a continued reduction in free trials and the majority of customers signing up for a first-month discounted price plan, allowing us to increase revenue velocity inside the customer population. We see ARPA stable at $14.97 in Q2, while the cancel rate is improving slightly to 3.4% sequentially and improved from 3.57% in Q2 of the previous year. Our smarter ad spend strategy, which centers around boosting profitability in customer acquisition continues to yield positive results. We have successfully automated and optimized this program leading to improved outcomes. Coupled with robust organic returns from our SEO initiatives and our refreshed eFax web presence, we are pleased to report that the SoHo business is meeting the intended objectives and marginally outperforming expectations as evidenced by certain stable key metrics. As a result, we expect to nominally increase our marketing spend using this new approach in the second half of 2024 by approximately $2 million. This concludes my update on our SoHo business. In closing, in light of ongoing economic uncertainty, cost awareness, and limited IT resources for our customers and prospects, their decision-making processes remain slow. To navigate these challenging market conditions, we maintain a high level of flexibility in our go-to-market approach and prioritize sales efficiency. We remain committed to our strategy with a strong focus on cash generation and profitability, while our go-to-market efforts will continue to center on driving growth within the corporate business. And now I'll hand the call over to our CFO, Jim Malone, who will provide further details about our financial results and guide.
Jim Malone: Thank you, Johnny, and good afternoon, everyone. In our press release and on this earnings call today, we are discussing Q2 2024 results and Q3 2024 guidance. We are reaffirming full-year 2024 revenue and adjusted EBITDA guidance while increasing our full-year adjusted EPS guidance range. We expect to file the 10-Q today. Let's start with our corporate business results. Q2 2024 revenue was a record at 51.7 million, an increase of 1.4 million or 2.7% over the prior year, and performing in line with our expectations. Corporate offer of $310 down from $317 or 2% in the prior year, and in line with the last several quarters ranging from $305 to $320. Q2 2024 customer churn of 2.29% increased the 103 basis points year over year and 37 basis points sequentially, primarily driven by new customers at the lower end of our customer continuum. As Johnny mentioned in his script, normalized for the eFax Protect project, the cancel rate would've been below 2%. Notwithstanding this, these customers are net economically beneficial, and I would also remind you that our cancel rate is based upon customers not revenue. Corporate delivered a trailing 12-month revenue retention of 99% and improvement over Q1 2024. Moving to SoHo, Q2 2024 revenue of 35.8 million is a decrease of 6.7 million or 15.8% over the prior year and better than our expectations. The year-over-year decrease was driven by planned reduced advertising spend and year-over-year base reduction due to fewer paid ads. With an increase of $0.02 sequentially, ARPA of $14.97 decreased 4.6% year-over-year as a result of shifting to price plans with a discounted first month versus a free trial resulting in higher paid ads in the quarter. These plans are net economically beneficial. Churn declined 17 basis points to 3.4% year-over-year and was in line with expectations. As you recall, Q2 2023 was the final quarter of our price increase cycle. Moving to Q2, consolidated results revenue of 87.5 million is a decrease of 5.3 million or 5.7% over Q2 2023 in line with our expectations and driven by the plan reduction in SoHo revenue. Adjusted EBITDA of 49.1 million an increase of 1.4 million or 2.9% over Q2 2023 was driven by the cost structure optimization primarily in the area of SoHo advertising. Adjusted EBITDA margin of 56.1% was 4.7 points above the prior year, exceeding expectations at the high end of our range, which is 55%. Adjusted net income of 28.1 million is an increase of 1.3 million or 4.9% over the prior year, driven by adjusted EBITDA flow through and net interest expense as a result of the bond repurchase activity offset by higher D&A and income tax expense. Adjusted EPS of $1.45 is higher than the prior year by 6.6% or $0.09 driven by the items I mentioned and a modestly lower share count. Q2 2024 non-GAAP tax rate and share count was 21.3% and 19.3 million shares both consistent with our Q2 guidance. Let's talk about our capital allocation strategy. As mentioned in our Q3, November 2023 earnings call, we announced a $300 million three-year bond repurchase program. In Q2 ‘24, we repurchased approximately 30 million face value for $28 million in cash. Program to date, we've repurchased 156 million face value for 143 million in cash. We have approximately 144 million in remaining under this program. Total debt to adjusted EBITDA leverage with a debt repurchases mentioned, our debt to adjusted EBITDA ratio is 3.1x well on our way to achieving our goal of 3x. We ended Q2 with 49 million in cash, which is sufficient to fund our operations and repurchases of debt and equity. Q2 free cash flow was 15.8 million or 295% positive versus the prior comparable period. Q2 2024 CapEx spend of 8.5 million is down 1.6 million versus the prior year. Based on our year-to-date results, we are increasing our full-year EPS guidance range and reaffirming full-year 2024 revenue and adjusted EBITDA guidance at the midpoint as follows: Revenue between 338 million and 353 million with 345 million at the midpoint; adjusted EBITDA between 182 million and 194 million with 188 million at the midpoint; adjusted EPS guidance range from $5.45 to $5.55 with $5.50 at the midpoint; our estimated share count and non-GAAP income tax rate was 19.3 million to 19.4 million shares; and a tax rate of 20.5% to 22.5%. For additional guidance within the quarter spread of guidance, we are providing Q3 2024 guidance results as follows: Revenues are expected to be between 83.5 million and 87.5 million with 85.5 million at the midpoint; adjusted EBITDA between 44.5 million and 47.5 million with 46 million at the midpoint; adjusted EPS between $1.25 to $1.35 with $1.30 at midpoint; Q3 2024 estimated share count; and income tax rates are 19.3 million to 19.4 million shares and a tax rate of 20.5% to 22.5% respectfully. This concludes my formal remarks. Now I'd like to turn the call back to the operator for Q&A.
Operator: [Operator Instructions] And the first question today is coming from Jon Tanwanteng from CJS Securities. Jon, your line is live.
Unidentified Analyst: It's Charlie [indiscernible] for Jon Tanwanteng in here. And my question with unemployment slightly teeing up -- a little bit. Do you think that the healthcare clients might be starting to be able to stack back up and reduce kind of the friction in deployments or is that still a ways off?
Johnny Hecker: You faded in and out? I'm not sure what the issue is with the audio. I know you had something to do about unemployment ticking up, but could you rephrase it again?
Unidentified Analyst: Yeah. Absolutely. Do you think that your healthcare clients might be starting to be able to stack back up and reduce kind of friction in deployment?
Johnny Hecker: Yeah, got it. Understood. So, interesting questions. It’s a good question. Appreciate it. Thank you. This is Johnny. So right now, we don't have any indicators that we see clients really finding the talent that they need to drive more IT projects. We don't see any changes in that dynamic in the market at all, to be honest.
Operator: [Operator Instructions] Next question is coming from David Larsen from BTIG. David, your line is open.
David Larsen: Hi, can you talk about the deployment process at the VA? How far along are you -- any metrics around like how many sites the VA has, how many you're deployed at? When did that start? And then when will you sort of get to sort of we'll call it, not a full ramp up, but a pretty good pace and the total dollars tied to the VA, just more color there would be very helpful. And how has that situation evolved? Is it improving in terms of access and deployment timing? Thanks very much.
Johnny Hecker: Yes. Hi David. This is Johnny. Good question. Thank you. I think it’s, we're at a -- we can't really say what percentage we're at on the site metric, they have about 2,200 sites of what we currently know but a site can be a handful of people operating an office at a cemetery, or it can be a huge hospital. So the site is not really a metric that gives us a good indication of volume. It's more about the number of employees, the number of seats that we have. And then beyond that what applications are these people using and we don't have a clear inventory of that at the moment. Remember we are rolling this out in close collaboration with our partner Accenture (NYSE:ACN) and Federal Services. They are driving the majority of the rollout at the site and training the end users. We are the provider of the infrastructure. Right now, like I said in my opening remarks, we're on pace, we're on track with the rollout of what we had expected but obviously, there is a tremendous potential in that account. We don't really want to put a final number on it because I don't think the VA knows themselves, it's a very, very large organization with hundreds of fax servers, thousands of multifunctional devices and machines that they're operating and they're step-by-step migrating over to the EC fax solution. So, as we go along and as we roll out, we will get a better understanding of how large that the total opportunity is. But we're still at the very beginning.
Scott Turicchi: And I would just add to what Johnny said, David, that in terms of the first part of your question, you’ll recall, it was really about a year ago, literally almost a year ago, September of ‘23, when the real rollout started because that first phase from March to June, July was really the test cases. And then there was a big bring down meeting to discuss both how those rollouts had been done, the format in which they had proceeded, and alternative ways because the VA has a similar incentive as we do, which is to see it roll out at a faster pace. And then that resulted in a number of months of going back and forth of alternative structures beyond just bringing a facility online. So the original view was, yes, it would be facility by facility, and eventually you'd be at 2,200. While that is still true and there's been a dramatic acceleration of the number of facilities that have access to the service. Since a year ago as Johnny pointed out, that's really -- it's only one of really several metrics that matter because I think, close to a million employees that are within the VA. So that constitutes another block of users. And then you've got embedded applications. And so what we have seen is what I'll call a liberalization of how the rollout is and will take place on a going-forward basis. So we're seeing basically each month, some degree of rollout relative to the previous month, and as a result, increasing traffic on a sequential basis. And so as Johnny referenced in his remarks we think two million-ish of revenue this year, which is like an infinite increase versus last year. But I would expect significant growth in that number as we go into ‘25, just based on the run rate exit that we'll have at the end of ‘24 before you even get to adding new users or new facilities in ‘25. So, I know that's not the exact quantification you want, but we're not going to give it to you because as Johnny pointed out, it's very challenging even with the VA. I think a lot of times, there's just so many different embedded applications and systems and regions that it's a challenge for them to even come up with what that number is.
James Malone: But I think we have several years of growth relative to where we sit today in terms of getting to what you might consider to be a meaning full -- not full penetration, but substantial penetration of the VA opportunity.
David Larsen: It sounds like things are improving is, is what I'm kind of hearing. And then also when you list - okay, was that a yes?
Johnny Hecker: Yes, that was a yes.
David Larsen: And then also when you listen to the publicly traded hospitals report, they each are consistently saying that labor shortages are being resolved. They're saying that inflation rates have improved. Their reliance on contract labor has been reduced. Volumes actually look very good at the publicly traded hospitals as do the EBITDA margins. I guess, any thoughts on like -- I guess this is similar to that first question, but any thoughts on the sort of demand level from the hospital market and the healthcare facilities that you're working with now? Has there been any improvement?
Johnny Hecker: Again, good question. Right now, we're seeing both sides of that coin. We see hospitals that are doing very well. I think they are covering on the clinical side, which is what you are hearing is that they're actually hiring that kind of staff. They're still very cost-conscious and trying to manage their bottom line as well. We don't see a necessarily increase in the IT staff, which is where we need most of the support. And then you also do see the flip side of the coin where you see hospitals that are in distress, right? I mean, very public is probably the Steward Health case that they just filed Chapter 11 recently. So I think you have both sides of that coin in the healthcare industry. You have the very large ones that are doing well. But you also have the ones that continue to struggle. Now, that's not necessarily bad for us, right, because they're looking to optimize their costs as well. And we can contribute to that. So we can use that as an opportunity to help them save some money and get rid of legacy infrastructure, which is usually costly. But on the labor side, we don't see a lot of improvement at the moment.
David Larsen: Okay. That's helpful. And there's just one more quick one from me. Any comments on the clarity prior auth solution or clarity clinical documentation? What sort of uptake rate are you seeing there and any way to sort of take a stab at total dollar, incremental dollar flow from your clients or incel opportunity? Thank you very much.
James Malone: Yes, so we do see increased interest in that product line. We have a lot of customer engagement, as I said, particularly in POCs. So we have to go through these motions. It is building backlog on our implementation teams, as we're building out that implementation capacity. But I think, it would be with that large amount of fax revenue that the company has, which is still growing, which we're adding to every quarter, the clarity contribution on the revenue side is not material at this point.
Scott Turicchi: Before we take any more live questions, Paul, we've got a couple of questions that have come in by email, which I'd like to address and then you can recheck for the queue if there's any other questions that want to come in. So we have a question regarding the SoHo business. It's really a perspective question to ‘25 about the expected rate of decline in SoHo in ‘25 versus ‘24, and how that might be changing given the increase in our marketing spend. So let me actually answer a question that's maybe even more near-term relevant, which is the last two-quarters of ‘24. So just so everybody understands, but we have a certain pace of spend in the first half of ‘24 that is substantially lower than the first half of ‘23. And some of that was in my prepared remarks. Some of that has been noted by Johnny and Jim. We have seen, based on the cohort analysis and based on the marketing programs, the ability to spend incrementally. Now from a budgetary standpoint or a forecast standpoint, we've assumed an incremental million dollars in each of Q3 and Q4. And as a result, that's particularly in the near term, I hit the EBITDA in the Q3 quarter. What I think is important to understand is that is not an authorized amount of spend, that's a budgeted amount of spend. The key is really that both the marginal contribution and the average of that spend maintains what we consider to be a strong LTV to CAC. If we see in given programs or chunks of programs that you just can't spend more beyond a certain limit, we don't intend to spend it. So a lot of the answer to the ‘25 question, or at least a portion of it, is a function of what will be the sustained level of marketing spend as we exit ‘24 and go into ‘25. It is our current expectation and certainly our hope we can fully spend that million dollars in each of Q3 and Q4. So you should be expecting a lesser decline in the SoHo business in Q3 and Q4. Those are easier comps for us than Q2, which was our toughest comp of the four quarters of this year. And then as we address the Q3 results on the November call, I think we'll have good insight in terms of what we expect in ‘25. I expect a lesser rate of decline in the SoHo business than we saw or seeing from ‘23 to ‘24. But in terms of quantifying it now, a lot of it will hinge on the exact level of marketing spend and what is that stabilized run rate as we look forward into ‘25. The second question had to do with one of capital deployment or CapEx. It's premised on the question of the nearing and refinancing. So I would just remind people that we have as was noted by Jim, 649 million of debt. There are two tranches of that. The 6% notes are due in October of ‘26, so more than two years away. Although, as the question is premised, I think we will be looking at what our options are certainly in ‘25 or at a minimum addressing the tranche that will be maturing in ‘26. The second tranche, which is larger, the 6.5 mature in October of ‘28. Our CapEx this year has been more front-end weighted. So we've given you a range of 26 million to 30 million for the year. We believe we're going to come in near the high end of the range for ‘24, around 30 million. So you'll see step-downs on a sequential basis in Q3 relative to Q2 and Q4 relative to Q3. This is really a budgetary question as it relates to our level of capital investment in ‘25. We obviously have not started that process yet. I would say sitting here today, I don't see any material change in the level of CapEx spend. Could it be 2 million or 3 million lower or 2 million or 3 million higher? Yes, a lot will be the function of what projects are we carrying into ‘25, which ones are we green lighting, which ones are we not green lighting, but I actually don't see the amount of CapEx on the margin as being in any way influential in terms of how we think about refinancing either tranche of debt. Paul, back to you if there's any more live questions.
Operator: There are no other live questions at this time, Scott.
Scott Turicchi: So we want to thank all of you for participating in our Q2 earnings call and look for press releases in terms of various upcoming conferences that we may be participating in. As I just mentioned, we will announce our Q3 results in the first, I think full week of November. So there'll be a press release as we get closer to the exact date and time. And, of course, if any of you have any other questions, you can reach out to us by email or call us as you digest the results. Thank you.
Operator: Thank you. This does conclude today's conference. You may disconnect at this time and have a wonderful day. Thank you for your participation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.